Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1987 | 5071 | 29.6 | 56% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
316 | 35223 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//SGLT2 INHIBITOR |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
5645 | 1528 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM//INDIRECT RESPONSE MODELS |
9503 | 1082 | INTERSPECIES SCALING//DMPK TRANSLAT SCI//WELL STIRRED MODEL |
12239 | 857 | BOF 4272//MULTIPLE INDICATOR DILUTION//HEPATIC ELIMINATION |
14872 | 675 | ASAN FDN//DA 125//MED DIAGNOST PATHOL |
16012 | 611 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//DISTRIBUTION CLEARANCE//CURVE MOMENTS |
26555 | 206 | INO 2628 CZ//DOUBLE PEAKS//DISCONTINUOUS ABSORPTION |
32124 | 112 | ORAL PHARMACOL THER EUT//PHARMACEUT SCI BIOPHARMACEUT MIZUHO KU//31 TANABE DORIMIZUHO KU |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | Journal | 171 | 42% | 6% | 311 |
2 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | Journal | 160 | 48% | 5% | 248 |
3 | NONMEM | Author keyword | 57 | 29% | 3% | 168 |
4 | INDIRECT RESPONSE MODELS | Author keyword | 40 | 82% | 0% | 23 |
5 | PL PHARMACOKINET | Address | 34 | 36% | 1% | 76 |
6 | ASAN FDN | Address | 33 | 83% | 0% | 19 |
7 | BIOPHARMACEUTICS & DRUG DISPOSITION | Journal | 26 | 11% | 4% | 212 |
8 | DA 125 | Author keyword | 23 | 86% | 0% | 12 |
9 | PHARMACOKINET DRUG THER Y | Address | 23 | 33% | 1% | 58 |
10 | INTERSPECIES SCALING | Author keyword | 22 | 53% | 1% | 30 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NONMEM | 57 | 29% | 3% | 168 | Search NONMEM | Search NONMEM |
2 | INDIRECT RESPONSE MODELS | 40 | 82% | 0% | 23 | Search INDIRECT+RESPONSE+MODELS | Search INDIRECT+RESPONSE+MODELS |
3 | DA 125 | 23 | 86% | 0% | 12 | Search DA+125 | Search DA+125 |
4 | INTERSPECIES SCALING | 22 | 53% | 1% | 30 | Search INTERSPECIES+SCALING | Search INTERSPECIES+SCALING |
5 | PHARMACOMETRICS | 22 | 42% | 1% | 40 | Search PHARMACOMETRICS | Search PHARMACOMETRICS |
6 | WELL STIRRED MODEL | 19 | 74% | 0% | 14 | Search WELL+STIRRED+MODEL | Search WELL+STIRRED+MODEL |
7 | DA 8159 | 19 | 64% | 0% | 18 | Search DA+8159 | Search DA+8159 |
8 | BOF 4272 | 18 | 89% | 0% | 8 | Search BOF+4272 | Search BOF+4272 |
9 | MODEL BASED DRUG DEVELOPMENT | 17 | 63% | 0% | 17 | Search MODEL+BASED+DRUG+DEVELOPMENT | Search MODEL+BASED+DRUG+DEVELOPMENT |
10 | POPULATION PHARMACOKINETICS | 16 | 12% | 2% | 120 | Search POPULATION+PHARMACOKINETICS | Search POPULATION+PHARMACOKINETICS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DOSAGE REGIMENS | 94 | 51% | 3% | 130 |
2 | PLASMA PARTITION COEFFICIENTS | 64 | 72% | 1% | 50 |
3 | INTRINSIC CLEARANCE | 62 | 45% | 2% | 104 |
4 | MULTIPLE INDICATOR DILUTION | 55 | 70% | 1% | 45 |
5 | HUMAN DRUG CLEARANCE | 52 | 80% | 1% | 32 |
6 | HEPATIC METABOLIC CLEARANCE | 47 | 81% | 1% | 29 |
7 | NONMEM | 44 | 38% | 2% | 91 |
8 | INDIRECT PHARMACODYNAMIC RESPONSES | 42 | 78% | 1% | 28 |
9 | LOCAL DISPOSITION | 41 | 90% | 0% | 18 |
10 | HEPATIC ELIMINATION | 37 | 61% | 1% | 40 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 171 | 42% | 6% | 311 |
2 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 160 | 48% | 5% | 248 |
3 | BIOPHARMACEUTICS & DRUG DISPOSITION | 26 | 11% | 4% | 212 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data | 2015 | 6 | 55 | 44% |
A novel strategy for physiologically based predictions of human pharmacokinetics | 2006 | 155 | 60 | 78% |
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science | 2011 | 161 | 164 | 29% |
Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches | 2009 | 102 | 44 | 59% |
The application of allometric scaling principles to predict pharmacokinetic parameters across species | 2014 | 5 | 42 | 79% |
The Simcyp (R) Population-based ADME Simulator | 2009 | 123 | 36 | 47% |
Pharmacokinetics | 2014 | 15 | 124 | 24% |
Prediction of Human Pharmacokinetics from Preclinical Information of Rhein, an Antidiabetic Nephropathy Drug, Using a Physiologically Based Pharmacokinetic Model | 2014 | 5 | 22 | 55% |
Model-based clinical drug development in the past, present and future: a commentary | 2015 | 1 | 28 | 64% |
Simulation of clinical trials | 2000 | 119 | 30 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PL PHARMACOKINET | 34 | 36% | 1.5% | 76 |
2 | ASAN FDN | 33 | 83% | 0.4% | 19 |
3 | PHARMACOKINET DRUG THER Y | 23 | 33% | 1.1% | 58 |
4 | PHARMACEUT EVALUAT 1 | 21 | 75% | 0.3% | 15 |
5 | MED DIAGNOST PATHOL | 21 | 90% | 0.2% | 9 |
6 | WOODMONT OFF 2 | 21 | 85% | 0.2% | 11 |
7 | SECT PHARMACOKINET | 18 | 44% | 0.6% | 31 |
8 | ASAN FDNASAN MED | 18 | 89% | 0.2% | 8 |
9 | DMPK TRANSLAT SCI | 15 | 88% | 0.1% | 7 |
10 | OFF CLIN PHARMACOL BIOPHARMACEUT | 14 | 39% | 0.6% | 28 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000018204 | APA HAMSTER//APA HAMSTERS//AMINO ACID LOAD |
2 | 0.0000016274 | PEPT1//PEPT2//HPEPT1 |
3 | 0.0000011884 | CYTOCHROME P450//CYP2D6//PREGNANE X RECEPTOR |
4 | 0.0000011699 | RAPID EQUILIBRIUM//UNSTABLE PRODUCT//ELECT ENGN ELECT AUTOMAT COMMUN |
5 | 0.0000009055 | TORASEMIDE//HYPERKALEMIA//FUROSEMIDE |
6 | 0.0000008834 | REGUCALCIN//SMP30//ENDOCRINOL MOL METAB |
7 | 0.0000008824 | BIOANALYSIS//LC NMR//DRIED BLOOD SPOT DBS |
8 | 0.0000008587 | CAFFEINE//COFFEE//ENERGY DRINKS |
9 | 0.0000006993 | CHEMOTHERAPY-TOKYO//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//CEFEPIME |
10 | 0.0000006714 | VISNAGIN//AMMI VISNAGA//FURANOCHROMONES |